Search results
Results from the WOW.Com Content Network
Surging demand has outpaced supply for Novo's Ozempic, Eli Lilly's Mounjaro and other GLP-1 drugs that promote weight loss, fueling a growing global market for counterfeit versions. The FDA said ...
The FDA said it found evidence the companies' websites offer the products, labeled for "research use only", for sale in the United States accompanied by claims such as weight loss, reducing the ...
The U.S. Food and Drug Administration (FDA) on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide, the active ingredients in ...
NEW YORK (Reuters) -U.S. Food and Drug Administration Commissioner Dr. Robert Califf said on Wednesday that he is very concerned about the prevalence of compounded and fake versions of highly in ...
Fake news websites are those which intentionally, but not necessarily solely, publish hoaxes and disinformation for purposes other than news satire. Some of these sites use homograph spoofing attacks , typosquatting and other deceptive strategies similar to those used in phishing attacks to resemble genuine news outlets.
The company has also filed lawsuits against sellers falsely claiming to sell FDA-approved versions of the drug. Reuters contributed to this report This article originally appeared on USA TODAY ...
The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly’s (LLY.N) blockbuster weight loss and diabetes drugs following a re-evaluation of their supply ...
Cansema is listed by the U.S. Food and Drug Administration (FDA) as one of 187 fake cancer cures. [4] Cansema continues to be marketed by numerous individuals, as evidenced by recent FDA Warning Letters. [21] The FDA has taken enforcement action against illegal marketing of Cansema as a cancer cure, as in the 2004 arrest and conviction of Greg ...